This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004 Jan;2(1):85; discussion 85.

doi: 10.1016/s1542-3565(03)00296-9.

Pretreatment antimicrobial susceptibility testing is not cost saving in the standard eradication of Helicobacter pylori

Asghar Qasim, Shaji Sebastian, Martin Buckley, Humphrey O'Connor, Colm O'Morain

PMID: 15017637
DOI: 10.1016/s1542-3565(03)00296-9

Comment

Pretreatment antimicrobial susceptibility testing is not cost saving in the standard eradication of Helicobacter pylori

Asghar Qasim et al. Clin Gastroenterol Hepatol. 2004 Jan.

. 2004 Jan;2(1):85; discussion 85.

doi: 10.1016/s1542-3565(03)00296-9.

Authors

Asghar Qasim, Shaji Sebastian, Martin Buckley, Humphrey O'Connor, Colm O'Morain

PMID: 15017637
DOI: 10.1016/s1542-3565(03)00296-9

No abstract available

PubMed Disclaimer

Comment on

Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
Romano M, Marmo R, Cuomo A, De Simone T, Mucherino C, Iovene MR, Montella F, Tufano MA, Del Vecchio Blanco C, Nardone G. Romano M, et al. Clin Gastroenterol Hepatol. 2003 Jul;1(4):273-8. Clin Gastroenterol Hepatol. 2003. PMID: 15017668 Clinical Trial.

Similar articles

Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
Romano M, Marmo R, Cuomo A, De Simone T, Mucherino C, Iovene MR, Montella F, Tufano MA, Del Vecchio Blanco C, Nardone G. Romano M, et al. Clin Gastroenterol Hepatol. 2003 Jul;1(4):273-8. Clin Gastroenterol Hepatol. 2003. PMID: 15017668 Clinical Trial.
Helicobacter pylori eradication in peptic dyspepsia.
Lule GN. Lule GN. East Afr Med J. 2005 Dec;82(12):601-2. East Afr Med J. 2005. PMID: 16619702 No abstract available.
Helicobacter pylori eradication in long-term proton pump inhibitor users is highly cost-effective: economic analysis of the HELPUP trial.
Mason JM, Raghunath AS, Hungin AP, Jackson W. Mason JM, et al. Aliment Pharmacol Ther. 2008 Dec 1;28(11-12):1297-303. doi: 10.1111/j.1365-2036.2008.03851.x. Epub 2008 Sep 14. Aliment Pharmacol Ther. 2008. PMID: 18793340 Clinical Trial.
Cost-effectiveness of H. pylori eradication.
Roesch W. Roesch W. J Physiol Pharmacol. 1996 Mar;47(1):71-7. J Physiol Pharmacol. 1996. PMID: 8777309 Review. No abstract available.
[How to eradicate Helicobacter pylori?].
Cayla R. Cayla R. Gastroenterol Clin Biol. 1996 Jan;20(1 Pt 2):S119-S130. Gastroenterol Clin Biol. 1996. PMID: 8734380 Review. French. No abstract available.

See all similar articles

Cited by

Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance.
Smith SM, O'Morain C, McNamara D. Smith SM, et al. World J Gastroenterol. 2014 Aug 7;20(29):9912-21. doi: 10.3748/wjg.v20.i29.9912. World J Gastroenterol. 2014. PMID: 25110421 Free PMC article. Review.
A Culture-Based Strategy Is More Cost Effective Than an Empiric Therapy Strategy in Managing Pediatric Helicobacter pylori Infection.
Hung CW, Chen SC, Ku LE, Sheu BS, Yang YJ. Hung CW, et al. Front Pediatr. 2022 May 3;10:860960. doi: 10.3389/fped.2022.860960. eCollection 2022. Front Pediatr. 2022. PMID: 35592847 Free PMC article.
Empirical vs. Susceptibility-Guided Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.
Nyssen OP, Espada M, Gisbert JP. Nyssen OP, et al. Front Microbiol. 2022 Jun 14;13:913436. doi: 10.3389/fmicb.2022.913436. eCollection 2022. Front Microbiol. 2022. PMID: 35774456 Free PMC article.
Empirical or susceptibility-guided treatment for Helicobacter pylori infection? A comprehensive review.
Gisbert JP. Gisbert JP. Therap Adv Gastroenterol. 2020 Nov 12;13:1756284820968736. doi: 10.1177/1756284820968736. eCollection 2020. Therap Adv Gastroenterol. 2020. PMID: 33240392 Free PMC article. Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information